CSLFINANCE price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- CSLFINANCE
- MB Code
- MBEQU1240
- ISIN
- INE718F01018
- BSE code
- 530067
- Industry group
- Finance
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 68.8 Cr
- Net profit
- 19.42 Cr
- EPS
- 8.46
- YoY revenue
- +21.71%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for CSLFINANCE
CSL's shares fell to an 8-year low following the announcement of CEO Paul McKenzie's departure and disappointing earnings results, raisin…
Dividend of ₹3.00 per share
Ex-date corporate action
CSL, Australia's fourth-largest company, plans to spin off its vaccine division and cut up to 3,000 jobs, leading to a significant drop i…
CSL plans to cut up to 15% of its staff and spin off its Seqirus business in a restructuring effort costing up to $770 million.
Price returns
Historical performance
Technicals
Indicator consensus